Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vered Stearns

Showing results (21-30 of 273) with videos related to

Pageof 28
Sort By:
Expert Opinion on Pharmacotherapy|May 2, 2009
Treatment strategies for hot flushesWen Shen, Vered Stearns
Oncology (Williston Park, N.Y.)|April 6, 2010
A multidisciplinary approach to neoadjuvant therapy for primary operable breast cancer. Challenges and opportunitiesRoisin Connolly, Vered Stearns
The Journal of Supportive Oncology|September 9, 2004
New therapeutic approaches for hot flashes in womenVered Stearns, Charles L Loprinzi
Current Treatment Options in Oncology|June 12, 2002
Approach to menopausal symptoms in women with breast cancerVered Stearns, Daniel F Hayes
Journal of the National Cancer Institute|December 13, 2007
Extended adjuvant therapy for breast cancer--how much is enough?Tatiana M Prowell, Vered Stearns
European Journal of Pharmacology|April 3, 2013
Current approaches for neoadjuvant chemotherapy in breast cancerRoisin M Connolly, Vered Stearns
ACP Journal Club|July 4, 2006
Disease-free survival was greater with letrozole than tamoxifen in postmenopausal women with early breast cancerTatiana M Prowell, Vered Stearns
JAMA Oncology|June 15, 2018
PIK3CA Mutations in Hormone Receptor-Positive Breast Cancers: PIKing Biomarkers to Inform Adjuvant Endocrine Therapy DecisionsVered Stearns, Ben Ho Park
Clinical Chemistry|June 23, 2009
Understanding resistance to tamoxifen in hormone receptor-positive breast cancerMichaela J Higgins, Vered Stearns
Oncology (Williston Park, N.Y.)|August 6, 2013
Postmenopausal hormone receptor-positive advanced breast cancerRoisin M Connolly, Vered Stearns
Pageof 28

Showing results (21-30 of 273) with videos related to

Sort By:
Pageof 28
Expert Opinion on Pharmacotherapy|May 2, 2009
Treatment strategies for hot flushesWen Shen, Vered Stearns
Oncology (Williston Park, N.Y.)|April 6, 2010
A multidisciplinary approach to neoadjuvant therapy for primary operable breast cancer. Challenges and opportunitiesRoisin Connolly, Vered Stearns
The Journal of Supportive Oncology|September 9, 2004
New therapeutic approaches for hot flashes in womenVered Stearns, Charles L Loprinzi
Current Treatment Options in Oncology|June 12, 2002
Approach to menopausal symptoms in women with breast cancerVered Stearns, Daniel F Hayes
Journal of the National Cancer Institute|December 13, 2007
Extended adjuvant therapy for breast cancer--how much is enough?Tatiana M Prowell, Vered Stearns
European Journal of Pharmacology|April 3, 2013
Current approaches for neoadjuvant chemotherapy in breast cancerRoisin M Connolly, Vered Stearns
ACP Journal Club|July 4, 2006
Disease-free survival was greater with letrozole than tamoxifen in postmenopausal women with early breast cancerTatiana M Prowell, Vered Stearns
JAMA Oncology|June 15, 2018
PIK3CA Mutations in Hormone Receptor-Positive Breast Cancers: PIKing Biomarkers to Inform Adjuvant Endocrine Therapy DecisionsVered Stearns, Ben Ho Park
Clinical Chemistry|June 23, 2009
Understanding resistance to tamoxifen in hormone receptor-positive breast cancerMichaela J Higgins, Vered Stearns
Oncology (Williston Park, N.Y.)|August 6, 2013
Postmenopausal hormone receptor-positive advanced breast cancerRoisin M Connolly, Vered Stearns
Pageof 28